Mativ vs Rayonier Advanced Materials
MATV and RYAM side by side, both in paper and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MATV and RYAM compare
Mativ is the larger company, worth 1.8 times as much as Rayonier Advanced Materials ($641M against $359M).
Mativ grew revenue faster over the last twelve months (1.1% versus −3.3% for Rayonier Advanced Materials).
Mativ keeps more of each dollar of sales as profit, with a net margin of 4.5% compared with −9.5% at Rayonier Advanced Materials.
Mativ pays a dividend yielding 3.4%; Rayonier Advanced Materials does not pay one.
Mativ scores higher on the StockData Score (15 against 1 for Rayonier Advanced Materials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MATV | RYAM |
|---|---|---|
| Size and price | ||
| Market cap | $641M | $359M |
| Share price | $11.61 | $5.30 |
| Change, 1 year | −12.0% | −10.8% |
| Change, 5 years | −63.0% | −7.2% |
| Beta (5Y) | 1.95 | 0.53 |
| Employees | 5,000 | 2,325 |
| StockData Score | ||
| Total score | 15 (better) | 1 |
| Valuation score | 6 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 7.2× | – |
| P/S | 0.3× | 0.2× (better) |
| P/B | 1.4× (better) | 1.8× |
| EV/EBITDA | 7.5× (better) | 12.5× |
| P/FCF | 5.0× | – |
| FCF yield | 19.9% | – |
| Fair value | $22.76 | $2.60 |
| Margin of safety | 49.0% (better) | −104% |
| Growth | ||
| Revenue growth (TTM) | 1.1% (better) | −3.3% |
| Revenue growth, 5Y average | 13.1% (better) | 1.8% |
| Profitability | ||
| Gross margin | 19.4% (better) | 5.9% |
| Operating margin | 3.5% (better) | −3.5% |
| Net margin | 4.5% (better) | −9.5% |
| FCF margin | 6.4% | – |
| Return on equity | 20.2% (better) | −52.1% |
| Return on invested capital | 3.9% (better) | −4.2% |
| Financial health | ||
| Debt / equity | 2.07 (better) | 3.98 |
| Net debt / EBITDA | 4.37 (better) | 8.36 |
| Interest coverage | 1.0× (better) | −0.5× |
| Current ratio | 1.98 (better) | 1.37 |
| Altman Z-score | 1.41 (better) | 0.88 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Dividend yield | 3.4% | – |
| Payout ratio | 25.0% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −25.6% | – |
| Shareholder yield | 3.4% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 93.9% | 79.8% |
| Held by insiders | 2.3% | 10.0% |
| Insider net buying, 12 months | – | −$17.6K |
| Short interest, % of float | 1.6% | 7.4% |
Go deeper
- MATV stock overview
- MATV income statement
- MATV valuation and score
- RYAM stock overview
- RYAM income statement
- RYAM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.